Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-027494)

Filing Details

Accession Number:: 0001209191-19-027494
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-03 17:30:53
Reporting Period:: 2019-05-01

Accepted Time:: 2019-05-03 17:30:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1016169	Antares Pharma Inc.	ATRS	Surgical & Medical Instruments & Apparatus (3841)	411350192

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1275012	J Thomas Garrity	C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-01	30,000	$0.53	190,213	No	4	M	Direct
Common Stock	Disposition	2019-05-01	30,000	$2.67	160,213	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-05-01	30,000	$0.00	30,000	$0.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-05-13	No	4	M	Direct

Footnotes

The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The stock options were due to expire on May 13, 2019.
The options vested and became exercisable in four equal quarterly installments following the grant date of May 14, 2009.